避孕器具市场规模、份额、成长分析、按产品类型、按技术、按分销管道、按地区 - 行业预测，2024-2031 年

2022年全球避孕器具市场规模为114.1亿美元，从2023年的120.3亿美元成长到2031年的183.2亿美元，在预测期内（2024-2031年）预计复合年增长率为5.4。

在避孕领域，预计透过旨在减少意外怀孕和降低医疗成本同时提高用户意识的计划来实现市场成长。各国政府和医疗保健组织正在推动「每个妇女每个儿童」、「千禧年发展目标」和「2030 年永续目标」(SDG) 等关键发展目标，以倡导计划生育和避孕药具的普及。私营和公共部门都为避孕药具的提供做出了重大贡献，其中私营部门主要提供避孕套和避孕药等短效方法。例如，在亚洲，约 41% 的女性私下获得避孕器，而 56% 的女性则依赖公共提供者。各国政府也进行大规模宣传活动和性教育计划，以促进青少年使用避孕药具，并获得世界卫生组织和疾病预防控制中心等组织的支持，以促进安全性行为。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 监管分析
• 专利分析
• 案例研究分析
• Start-Ups分析

依产品类型分類的避孕器具市场规模及复合年增长率（2024-2031）

• 市场概况
• 男性避孕器
• 女性避孕器
• 女性用避孕套子宫託海绵
• 避孕环
• 子宫内避孕器
• 皮下植入
• 其他的

避孕器具市场规模：依技术及复合年增长率（2024-2031）

• 市场概况
• 荷尔蒙避孕药
• 屏障避孕器

避孕器具市场规模：依通路及复合年增长率（2024-2031）

• 市场概况
• 医院药房
• 零售药房
• 诊所
• 线上管道
• 公共管道和非政府组织
• 其他的

避孕器具市场规模及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Bayer AG（Germany）
• Pfizer Inc.（US）
• Janssen Global Services, LLC（US）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Merck Sharp & Dohme Corp.（US）
• Mylan NV（US）
• Reckitt Benckiser Group plc.（UK）
• Veru Inc.（US）
• Medisafe Distribution Inc.（Canada）
• CooperSurgical, Inc.（US）
• Devex（US）
• Mayer Laboratories, Inc.（US）
• Allergan plc（Ireland）
• Agile Therapeutics（US）
• HLL Lifecare（India）
• Ansell Ltd（Australia）
• Mankind Pharma（India）
• TTK HealthCare（India）
• Boehringer Ingelheim International GmbH.（Germany）
• V-Care Pharma Pvt. Ltd.（India）

结论和建议

Global Contraceptive Devices Market size was valued at USD 11.41 billion in 2022 and is poised to grow from USD 12.03 billion in 2023 to USD 18.32 billion by 2031, growing at a CAGR of 5.4% during the forecast period (2024-2031).

Market growth in the contraceptive sector is anticipated through programs aimed at reducing unintended pregnancies and healthcare costs while enhancing user awareness. Key initiatives such as Every Woman Every Child, Millennium Development Goals, and the 2030 Sustainable Development Goals (SDGs) are being spearheaded by governments and healthcare organizations to advocate for family planning and contraceptive utilization. Both private and public sectors significantly contribute to contraceptive provision, with the private sector predominantly supplying short-acting methods like condoms and pills. For instance, in Asia, around 41% of women source contraceptives privately, while 56% rely on public providers. Governments are also implementing extensive campaigns and sex education programs to promote contraceptive use among youth, receiving support from organizations like the WHO and CDC in fostering safe sex practices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contraceptive Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contraceptive Devices Market Segmental Analysis

Global Contraceptive Devices Market is segmented by product type, technology, distribution channel and region. Based on product type, the market is segmented into male contraceptive devices, female contraceptive devices, female condoms, diaphragms & sponges, vaginal rings, intrauterine devices, sub-dermal implants and others. Based on technology, the market is segmented into hormonal contraceptives and barrier contraceptives. Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, clinics, online channels, public channel & ngo and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Contraceptive Devices Market

The Global Contraceptive Devices market is significantly driven by the introduction of highly efficient, non-hormonal intrauterine devices (IUDs). This innovative contraceptive technology presents a reliable and long-lasting option for women, combining a unique design that prioritizes safety and ease of use. The non-hormonal aspect reduces the likelihood of side effects, making it an attractive alternative for those who may be sensitive to hormonal contraception. Its effectiveness and user-friendly features cater to women's needs for convenience and dependability in birth control, thus enhancing its appeal in the market and potentially boosting overall demand for contraceptive solutions globally.

Restraints in the Global Contraceptive Devices Market

The Global Contraceptive Devices market faces certain constraints, particularly concerning the heightened risk of infections associated with the use of these devices. While contraceptive devices are designed to empower individuals in making informed reproductive health choices, the potential for infections can undermine their effectiveness and safety. The reliance on various methods, such as condoms, intrauterine devices (IUDs), and hormonal implants, is intended to provide reliable birth control and promote reproductive autonomy. However, concerns surrounding hygiene and the risks of complications can deter some users, hindering the broader acceptance and implementation of these essential tools for family planning and responsible sexual health practices.

Market Trends of the Global Contraceptive Devices Market

The Global Contraceptive Devices market is experiencing robust growth, driven by escalating rates of unwanted pregnancies and a heightened awareness of family planning methods. The rising incidence of sexually transmitted infections (STIs) and increased government funding for family planning initiatives further bolster market expansion. An array of contraceptive options including condoms, intrauterine devices, oral contraceptives, and subdermal implants, combined with growing consumer purchasing power, are notable contributors. Additionally, the surge in e-commerce, advancements in long-acting reversible contraceptives, and a trend towards innovative products align with the demand for non-hormonal and female-controlled contraceptives, thereby fueling continued market development.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis
• Case Study Analysis
• Startup Analysis

Global Contraceptive Devices Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Male Contraceptive Devices
• Female Contraceptive Devices
• Female Condoms, Diaphragms & Sponges
• Vaginal Rings
• Intrauterine Devices
• Sub-Dermal Implants
• Others

Global Contraceptive Devices Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Hormonal Contraceptives
• Barrier Contraceptives

Global Contraceptive Devices Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Online Channels
• Public Channel & Ngo
• Others

Global Contraceptive Devices Market Size & CAGR (2024-2031)

• North America (Product Type, Technology, Distribution Channel)
  • USA
  • Canada
• Europe (Product Type, Technology, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janssen Global Services, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Sharp & Dohme Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veru Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisafe Distribution Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Devex (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HLL Lifecare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ansell Ltd (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mankind Pharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK HealthCare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• V-Care Pharma Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations